Triple Hair
Triple Hair
  • Publications
  • Contact
  • FR
  • Products
    • PRESCRIPTION
      • Therapy-07
    • DRUG-FREE
      • Therapy-16
    • RIZN
    • Plenty Natural
  • Company
  • Science
  • Investors
  • Clinical trials
  • Products
    • PRESCRIPTION l Therapy-7
    • DRUG-FREE l Therapy-16
    • Hair Loss Rx Consult
    • RIZN
    • Plenty Natural
  • Company
  • Science
  • Investors
  • Clinical trials

Houfar Sekhavat, MD

Posted on June 7, 2020 (June 9, 2020) by Jean-Philippe Gravel

Post navigation

 Peter Ford, Pharma DJean-Philippe Gravel, MBA 

Search

Recent Posts

  • TH07 Clinical Study Featured in Peer-Reviewed Scientific Journal
  • Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India
  • Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe
  • Triple Hair’s Feature in Le Journal de Montréal
  • Triple Hair Group Closes $4 Million Financing

Recent Comments

    Triple Hair is a clinical-stage Canadian
    biotechnology company specialized in the
    development of innovative treatments for alopecia.

    Revolutionary
    hair growth
    therapies

    • Company
    • Products
    • Therapy-07
    • Science
    • Contact
    • Therapy-16
    • Investors
    • Terms and Conditions
    • Privacy Policy

    Copyright © 2020 | Triple Hair

    Clinical Trials
    Looking to invest?